We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cell and Gene Therapy Catapult, UCLB and Imperial Innovations Announce Positive Interim Review

News   Apr 13, 2016

 
Cell and Gene Therapy Catapult, UCLB and Imperial Innovations Announce Positive Interim Review
 
 
 

RELATED ARTICLES

Bioactive Agents Improve Synthetic Bone Substitutes

News

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.

READ MORE

Plant-based Compound Helps Overcome Gene Therapy Challenges

News

Researchers believe they have found a way to sidestep some of the current difficulties associated with gene therapy, resulting in a better method that would save money and improve treatment outcomes.

READ MORE

Developing Pioneering Cell Therapies for Immunotherapy Non-responders

News

New research signposts a novel, less invasive method to identify killer T lymphocytes in patients with gastrointestinal tumors with low mutational burden who are refractory to currently-approved immune-based treatments.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE